Published in

Elsevier, Value in Health, 7(19), p. A866-A867

DOI: 10.1016/j.jval.2016.08.393

Links

Tools

Export citation

Search in Google Scholar

Cost-effectiveness of apixaban versus warfarin in chinese patients with non-valvular atrial fibrillation

Journal article published in 2016 by Ew Chan, Lau Cy, Chan Ewy, X. Li ORCID, S. Anand
This paper is available in a repository.
This paper is available in a repository.

Full text: Download

Green circle
Preprint: archiving allowed
Upload
Orange circle
Postprint: archiving restricted
Upload
Red circle
Published version: archiving forbidden
Policy details
Data provided by SHERPA/RoMEO

Abstract

OBJECTIVES: To evaluate the cost-effectiveness of apixaban versus warfarin in Chinese patients with non-valvular atrial fibrillation (NVAF) from the Hong Kong public institutional perspective . ; postprint